Origin Achieves ISO 13485 Certificate for Best Practice in Medical Devices
Origin have invested £12 million in a state-of-the-art ISO 5 filling facility. As part of the facility we have developed a kitting service.
As a leading UK pharmaceutical packaging company, Origin are pleased to announce we have been awarded ISO 13485 certification following an in-depth audit.
The internationally agreed ISO standard is the main standard for medical devices and demonstrates to regulators our ongoing commitment to quality and best practice.
ISO 13485 is a stringent standard Origin can apply to control systems and processes to ensure the safety and efficacy of its medical devices.
The certification will support ongoing customer partnerships and open new opportunities where ISO 13485 is a pre-requisite for doing business, assuring customers that the Medical Device / IVD products they intend to purchase will meet their requirements for quality.
It will also allow Origin to sell medical devices in major markets such as the EU and Canada.
The achievement follows years of investment by Origin into state-of-the-art facilities, the introduction of nearly 50 new QMS policies and procedures, the allocation of over 750 work hours to audit-related activity, and two compliance audits by the certification body with involvement from many departments.
Gaining ISO 13485 status will help Origin achieve its business goals of growing its reputation within the competitive healthcare sector – particularly among big pharma, upholding customer satisfaction, promoting better decision making, creating a culture of continual improvement and increasing employee engagement.
Staff across the business have access to standards documentation, helping to identify any issues, improve products and streamline the manufacturing process.
All ISO standards are reviewed every five years to consider whether revision is required to keep it current and relevant for the marketplace. ISO 13485 (2016) is designed to respond to the latest quality management system practices, including changes in technology and regulatory requirements and expectations.
Rich Quelch, Global Head of Marketing commented:
“Being awarded ISO 13485 status is a testament to Origin’s commitment to the highest safety and quality standards in its medical devices and packaging. We’re incredibly proud of this achievement and it marks an important milestone for Origin – it will support us to engage with more pharmaceutical and healthcare companies globally.”
Related News
-
Sponsored Content Ashwagandha and Herbal Medicines: Pharma’s Next Big Opportunity
Herbal medicines and nutraceuticals have seen a surge in interest since the onset of the COVID-19 pandemic. Driven by patient interest in prioritising personalised and integrative medicines, the herbal ingredients industry is now faced with concerns pe... -
Sponsored Content Discover Our Organic Mineral Salts as APIs
Discover the range of organic mineral salts that serve as Active Pharmaceutical Ingredients available from Dr. Paul Lohmann®. -
Sponsored Content CPHI Podcast Series: Ursatec – celebrating 30 years of pioneering preservative free
In the latest episode of the CPHI Podcast Series, Digital Editor Lucy Chard spoke with Dominik Rocchi of Ursatec. -
Sponsored Content How healthcare trends inform dosage forms
Capsules encompass one of the most popular solid oral dosage forms for pharmaceutical products, with the global empty capsule market predicted to rise to USD $3.7 billion by 2026. The growth in the capsule market can be partly attributed to the many op... -
Sponsored Content 2023 Pharma Trend Outlook: Innovation, Resilience, and Pharma 4.0
Download our 2023 Pharma Trends Outlook report to discover the trends set to shape the pharmaceutical landscape in the new year, with expert opinions and insight from across the pharmaceutical value chain. -
Sponsored Content CPHI Podcast Series: Key Considerations in Selecting the Right CMO Partner
In this month's episode we hear from Jayna Blake, Senior Project Manager for Technical Programs at Baxter BioPharma Solutions, on key considerations for successful CMO selection. -
Sponsored Content Size doesn’t matter: How smaller deals are shaping healthcare M&A
Several mega-deals have made a splash in the pharma and life sciences industries over recent years – from AstraZeneca’s acquisition of Alexion for $39 billion to Gilead Sciences’ $21 billion purchase of Immunomedics. With am... -
Sponsored Content Rise in home-based healthcare shaping pharma packaging and drug delivery
The pharma packaging and drug delivery industry has long been synonymous with rapid innovation. As medicine advances and patient needs change, so too should drug packaging and devices. This has been particularly evident during the pandem...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance